TWO SIGMA INVESTMENTS, LP - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 203 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$2,133,000
-41.9%
60,954
-46.2%
0.01%
-33.3%
Q3 2019$3,671,000
+28.1%
113,306
+97.3%
0.01%
+20.0%
Q2 2019$2,865,000
-73.1%
57,440
-75.1%
0.01%
-76.2%
Q4 2018$10,638,000
+77.0%
230,710
+196.1%
0.04%
+162.5%
Q3 2018$6,009,000
-52.1%
77,918
-47.6%
0.02%
-56.8%
Q2 2018$12,536,000
+12.9%
148,830
+9.6%
0.04%0.0%
Q1 2018$11,106,000
+264.7%
135,807
+155.0%
0.04%
+270.0%
Q4 2017$3,045,000
-10.3%
53,265
+4.8%
0.01%
-16.7%
Q3 2017$3,393,000
+1257.2%
50,831
+2159.2%
0.01%
+1100.0%
Q2 2015$250,0002,2500.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders